'Rejuvenation' protects neurons in mouse models of Parkinson's disease
- PMID: 17558391
- DOI: 10.1038/nature05865
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
Abstract
Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual reliance of these neurons on L-type Ca(v)1.3 Ca2+ channels to drive their maintained, rhythmic pacemaking renders them vulnerable to stressors thought to contribute to disease progression. The reliance on these channels increases with age, as juvenile dopamine-containing neurons in the substantia nigra pars compacta use pacemaking mechanisms common to neurons not affected in Parkinson's disease. These mechanisms remain latent in adulthood, and blocking Ca(v)1.3 Ca2+ channels in adult neurons induces a reversion to the juvenile form of pacemaking. Such blocking ('rejuvenation') protects these neurons in both in vitro and in vivo models of Parkinson's disease, pointing to a new strategy that could slow or stop the progression of the disease.
Comment in
-
Neurophysiology: stressful pacemaking.Nature. 2007 Jun 28;447(7148):1059-60. doi: 10.1038/4471059a. Nature. 2007. PMID: 17597746 No abstract available.
Similar articles
-
Neurophysiology: stressful pacemaking.Nature. 2007 Jun 28;447(7148):1059-60. doi: 10.1038/4471059a. Nature. 2007. PMID: 17597746 No abstract available.
-
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
-
A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.Mov Disord. 2010;25 Suppl 1:S63-70. doi: 10.1002/mds.22801. Mov Disord. 2010. PMID: 20187241
-
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.Cell Calcium. 2010 Feb;47(2):175-82. doi: 10.1016/j.ceca.2009.12.003. Epub 2010 Jan 6. Cell Calcium. 2010. PMID: 20053445 Free PMC article. Review.
-
Calcium, ageing, and neuronal vulnerability in Parkinson's disease.Lancet Neurol. 2007 Oct;6(10):933-8. doi: 10.1016/S1474-4422(07)70246-6. Lancet Neurol. 2007. PMID: 17884683 Review.
Cited by
-
Spatial and temporal scales of dopamine transmission.Nat Rev Neurosci. 2021 Jun;22(6):345-358. doi: 10.1038/s41583-021-00455-7. Epub 2021 Apr 9. Nat Rev Neurosci. 2021. PMID: 33837376 Free PMC article. Review.
-
Age-mediated transcriptomic changes in adult mouse substantia nigra.PLoS One. 2013 Apr 30;8(4):e62456. doi: 10.1371/journal.pone.0062456. Print 2013. PLoS One. 2013. PMID: 23638090 Free PMC article.
-
Identification of neurodegenerative factors using translatome-regulatory network analysis.Nat Neurosci. 2015 Sep;18(9):1325-33. doi: 10.1038/nn.4070. Epub 2015 Jul 27. Nat Neurosci. 2015. PMID: 26214373 Free PMC article.
-
K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration.Nat Neurosci. 2012 Sep;15(9):1272-80. doi: 10.1038/nn.3185. Epub 2012 Aug 19. Nat Neurosci. 2012. PMID: 22902720 Free PMC article.
-
Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.J Clin Invest. 2012 Apr;122(4):1354-67. doi: 10.1172/JCI61332. Epub 2012 Mar 26. J Clin Invest. 2012. PMID: 22446186 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous